FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310343828> ?p ?o ?g. }

• W4310343828 endingPage "998" @default.
• W4310343828 startingPage "979" @default.
• W4310343828 abstract "Background: Polycystic ovarian syndrome (PCOS) is a common, reproductive endocrinopathy associated with ovarian dysfunction, cardiovascular disorders, obesity, and infertility. Myo-inositol is a novel treatment for women with PCOS that claimed to have improved fertility rate in this population. This systematic review and meta-analysis examined the effect of myo-inositol on pregnancy rate, menstrual cycle, and adverse effects from randomized controlled trials (RCTs). Methods: RCTs that evaluated the efficacy of myo-inositol in improving pregnancy rate and regulation of menstrual cycle in women with PCOS. Electronic databases were searched and studies published up to October 24, 2021 were included in the systematic review and meta-analysis. Study selection and assessment of quality were conducted independently by two review authors. Results: Seven studies with 729 patients treated with myo-inositol and 677 patients treated with placebo and/or metformin were included in the analysis. The research groups did not diverge significantly in terms of basic characteristics, such as age, adnexal or uterine pathology, body mass index, and duration of infertility. In the myo-inositol group, regulation of the normal menstrual cycle is at 20%, significantly higher than the metformin group at 12%, (p<0.001). However, there is no significant difference in the pregnancy rate between myoinositol and placebo (p=0.42) and/or metformin (p=0.17). Conclusion: This systematic review and meta-analysis showed that myo-inositol can be an alternative treatment for PCOS in terms of regulation of menses and may improve the success of spontaneous pregnancies. However, additional randomized, double-blind controlled trials with larger sample sizes, low heterogeneity, and uniform inclusion criteria are recommended to establish the effects of myo-inositol on PCOS treatment and pregnancy rate." @default.
• W4310343828 created "2022-12-09" @default.
• W4310343828 creator A5033426952 @default.
• W4310343828 creator A5051904726 @default.
• W4310343828 date "2022-10-31" @default.
• W4310343828 modified "2023-09-26" @default.
• W4310343828 title "Efficacy of Myo-inositol in Improving Pregnancy Rate and Regulation of Menstrual Cycle for Patients With Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis" @default.
• W4310343828 cites W1844254983 @default.
• W4310343828 cites W1965166422 @default.
• W4310343828 cites W2040559403 @default.
• W4310343828 cites W2044406786 @default.
• W4310343828 cites W2072290318 @default.
• W4310343828 cites W2125435699 @default.
• W4310343828 cites W2339183712 @default.
• W4310343828 cites W2510252049 @default.
• W4310343828 cites W2582276505 @default.
• W4310343828 cites W2607125527 @default.
• W4310343828 cites W2616274339 @default.
• W4310343828 cites W2623841334 @default.
• W4310343828 cites W2908602350 @default.
• W4310343828 cites W2910430746 @default.
• W4310343828 cites W2921299767 @default.
• W4310343828 cites W2925323220 @default.
• W4310343828 cites W2998933501 @default.
• W4310343828 cites W3114790766 @default.
• W4310343828 cites W3123757349 @default.
• W4310343828 doi "https://doi.org/10.35460/2546-1621.2021-0141" @default.
• W4310343828 hasPublicationYear "2022" @default.
• W4310343828 type Work @default.
• W4310343828 citedByCount "0" @default.
• W4310343828 crossrefType "journal-article" @default.
• W4310343828 hasAuthorship W4310343828A5033426952 @default.
• W4310343828 hasAuthorship W4310343828A5051904726 @default.
• W4310343828 hasBestOaLocation W43103438281 @default.
• W4310343828 hasConcept C126322002 @default.
• W4310343828 hasConcept C131872663 @default.
• W4310343828 hasConcept C134018914 @default.
• W4310343828 hasConcept C142724271 @default.
• W4310343828 hasConcept C168563851 @default.
• W4310343828 hasConcept C204787440 @default.
• W4310343828 hasConcept C27081682 @default.
• W4310343828 hasConcept C2776537878 @default.
• W4310343828 hasConcept C2777391703 @default.
• W4310343828 hasConcept C2777688143 @default.
• W4310343828 hasConcept C2779058012 @default.
• W4310343828 hasConcept C2779234561 @default.
• W4310343828 hasConcept C2779306644 @default.
• W4310343828 hasConcept C2780323712 @default.
• W4310343828 hasConcept C2908647359 @default.
• W4310343828 hasConcept C29456083 @default.
• W4310343828 hasConcept C3018442814 @default.
• W4310343828 hasConcept C42407357 @default.
• W4310343828 hasConcept C511355011 @default.
• W4310343828 hasConcept C54355233 @default.
• W4310343828 hasConcept C71315377 @default.
• W4310343828 hasConcept C71924100 @default.
• W4310343828 hasConcept C86803240 @default.
• W4310343828 hasConcept C95190672 @default.
• W4310343828 hasConcept C99454951 @default.
• W4310343828 hasConceptScore W4310343828C126322002 @default.
• W4310343828 hasConceptScore W4310343828C131872663 @default.
• W4310343828 hasConceptScore W4310343828C134018914 @default.
• W4310343828 hasConceptScore W4310343828C142724271 @default.
• W4310343828 hasConceptScore W4310343828C168563851 @default.
• W4310343828 hasConceptScore W4310343828C204787440 @default.
• W4310343828 hasConceptScore W4310343828C27081682 @default.
• W4310343828 hasConceptScore W4310343828C2776537878 @default.
• W4310343828 hasConceptScore W4310343828C2777391703 @default.
• W4310343828 hasConceptScore W4310343828C2777688143 @default.
• W4310343828 hasConceptScore W4310343828C2779058012 @default.
• W4310343828 hasConceptScore W4310343828C2779234561 @default.
• W4310343828 hasConceptScore W4310343828C2779306644 @default.
• W4310343828 hasConceptScore W4310343828C2780323712 @default.
• W4310343828 hasConceptScore W4310343828C2908647359 @default.
• W4310343828 hasConceptScore W4310343828C29456083 @default.
• W4310343828 hasConceptScore W4310343828C3018442814 @default.
• W4310343828 hasConceptScore W4310343828C42407357 @default.
• W4310343828 hasConceptScore W4310343828C511355011 @default.
• W4310343828 hasConceptScore W4310343828C54355233 @default.
• W4310343828 hasConceptScore W4310343828C71315377 @default.
• W4310343828 hasConceptScore W4310343828C71924100 @default.
• W4310343828 hasConceptScore W4310343828C86803240 @default.
• W4310343828 hasConceptScore W4310343828C95190672 @default.
• W4310343828 hasConceptScore W4310343828C99454951 @default.
• W4310343828 hasIssue "2" @default.
• W4310343828 hasLocation W43103438281 @default.
• W4310343828 hasOpenAccess W4310343828 @default.
• W4310343828 hasPrimaryLocation W43103438281 @default.
• W4310343828 hasRelatedWork W1835582227 @default.
• W4310343828 hasRelatedWork W1986311037 @default.
• W4310343828 hasRelatedWork W1994593372 @default.
• W4310343828 hasRelatedWork W2005084305 @default.
• W4310343828 hasRelatedWork W2020998291 @default.
• W4310343828 hasRelatedWork W2031854978 @default.
• W4310343828 hasRelatedWork W2033313326 @default.
• W4310343828 hasRelatedWork W2057266706 @default.
• W4310343828 hasRelatedWork W2348872348 @default.
• W4310343828 hasRelatedWork W2744240433 @default.

• next